BIOCEPT INC (BIOC) Earnings History & Surprises

NASDAQ:BIOCUS09072V6002

Current stock price

0.4349 USD
-0.07 (-13.05%)
At close:
0.39 USD
-0.04 (-10.32%)
After Hours:

BIOC Earnings overview

Past quarterly earnings results for BIOCEPT INC (BIOC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 20, 2023
Period
Q3 / 2023
EPS Estimate
-$2.78
Revenue Estimate
613.02K

Last Reported

Most Recent
Release Date
Aug 14, 2023
Period
Q2 / 2023
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2023 - - 589K - -94.45%
Q1 2023 - - 673K - -96.63%
Q4 2022 -32.70 -7.50 -336.17% -18,066.67% 25.858M 3.331M 676.28% 85.02%
Q3 2022 -9.90 -5.97 -65.91% -33,100.00% 1.007M 9.721M -89.64% -94.24%
Q2 2022 -0.31 -0.16 -89.95% -121.43% 10.611M 12.723M -16.60% -11.92%
Q1 2022 -0.16 -0.14 -12.04% -184.21% 19.945M 11.72M 70.18% 12.30%
Q4 2021 -0.18 -0.19 7.12% -228.57% 13.976M 11.33M 23.36% -24.49%
Q3 2021 0.03 0.07 -54.75% 106.98% 17.47M 16.392M 6.57% 165.09%
Q2 2021 -0.14 -0.16 14.22% 72.00% 12.047M 9.935M 21.26% 1,209.48%
Q1 2021 0.19 - 117.27% 17.76M - 1,124.83%
Q4 2020 0.14 -0.28 150.84% - 18.51M 12.568M 47.28% -
Q3 2020 -0.43 -0.48 10.30% - 6.59M 2.556M 157.82% -
Q2 2020 -0.50 -0.51 1.96% - 920K 1.326M -30.62% -
Q1 2020 -1.10 - - 1.45M 1.944M -25.41% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

BIOC EPS Q2Q GrowthBIOC EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q3/23 Q4/23 0 -10K -20K -30K

Revenue Historical Q2Q growth and Acceleration

BIOC Revenue Q2Q GrowthBIOC Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 200 400 600 800 1K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

BIOCEPT INC / BIOC Earnings FAQ

What is the most recent earnings date for BIOC stock?

BIOCEPT INC (BIOC) last reported earnings on 8/14/2023.

Did BIOC stock beat earnings estimates in the most recent quarter?

BIOCEPT INC (BIOC) missed EPS estimates and missed revenue estimates in the most recent quarter.